Enlivex Therapeutics Ltd is a biotechnology company focused on developing innovative therapies to harness the body’s immune system to treat a range of serious conditions
The company specializes in the research and development of cell therapy products aimed at modulating the immune response, particularly in the context of autoimmune diseases and other severe health conditions. With a commitment to advancing novel treatments, Enlivex aims to improve patient outcomes through its cutting-edge technological approaches and potential game-changing medical solutions.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26.
U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21.
Shares of RayzeBio, Inc. (NASDAQRYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.
Enlivex Therapeutics Ltd. (NASDAQENLV) announced that the U.S. Food & Drug Administration (FDA) had cleared an Investigational New Drug (IND) application to study Allocetra™ in patients with advanced solid malignancies.
Enlivex Therapeutics Ltd. (NASDAQENLV) announced that Israel, Spain and Greece have cleared amendments to the company’s Phase II trial protocol that will allow the study to enroll more patients.
Since Robert Hooke discovered cells in 1665 and Theodor Schwann proposed the classical cell theory in 1839, the cell therapy industry has grown by leaps and bounds.
